Skip to main content

COVID-19 plasma trial at UW-Madison shows treatment helped 94% of severely ill patients avoid ICU or ventilation

Patients with severe or life-threatening COVID-19 have fared well so far in two clinical trials underway at the University of Wisconsin-Madison, according to preliminary results.

The university also launched three new COVID-19 clinical trials and began considering offers to host another nine. Since the coronavirus clinical trials began, 80% of all UW Health patients with COVID-19 have been enrolled in one.